R

Redhill Biopharma Ltd

D
RDHL
USD
0.09
(0.9119%)
Market Closed
529.00
Volume
-1.1
EPS
-
Div Yield
-0.032912
P/E
12,754,168.44
Market Cap
Today
0.9119%
1 Week
-9.124%
1 Month
23.650%
6 Months
-25.267%
12 Months
-51.415%
Year To Date
-72.524%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
T
TEVA
-0.105
(-0.5876%)
USD
B
BCLI
0.0006
(0.25%)
USD
O
OPK
-0.03
(-1.8519%)
USD
P
PLX
0.05
(4.5455%)
USD
I
IRWD
-0.015
(-0.3315%)
USD

Title:
Redhill Biopharma Ltd

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company alsocommercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.
Do you need help or have a question?
Contact Us